Cargando…
Activating mutation in MET oncogene in familial colorectal cancer
BACKGROUND: In developed countries, the lifetime risk of developing colorectal cancer (CRC) is 5%, and it is the second leading cause of death from cancer. The presence of family history is a well established risk factor with 25-35% of CRCs attributable to inherited and/or familial factors. The high...
Autores principales: | Neklason, Deborah W, Done, Michelle W, Sargent, Nykole R, Schwartz, Ann G, Anton-Culver, Hoda, Griffin, Constance A, Ahnen, Dennis J, Schildkraut, Joellen M, Tomlinson, Gail E, Strong, Louise C, Miller, Alexander R, Stopfer, Jill E, Burt, Randall W |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2011
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3202244/ https://www.ncbi.nlm.nih.gov/pubmed/21970370 http://dx.doi.org/10.1186/1471-2407-11-424 |
Ejemplares similares
-
Deciphering the molecular pathways disrupted in normal and neoplastic colonic tissue in inherited colorectal cancer syndromes
por: Neklason, Deborah W, et al.
Publicado: (2011) -
Shortcuts to genetic characterization of polyposis patients in a high-risk registry
por: Done, Michelle W, et al.
Publicado: (2011) -
Mutation-negative FAP patients with mRNA defects of APC
por: Condie, Michelle W, et al.
Publicado: (2010) -
Differential gene expression in primary colonic tissue from control, FAP and AFAP patients reveals unique signatures with diagnostic potential
por: Neklason, Deborah W, et al.
Publicado: (2010) -
Descriptive review and comparison of clinical outcomes of AFAP patients
por: McCoy, Heidi, et al.
Publicado: (2011)